Drug-resistant bacteria possess natural ability to become vulnerable to antibiotics
Infections with one of the most troublesome and least
understood antibiotic-resistant “superbugs” are increasing at alarming
rates, particularly in health-care settings. But by studying A. baumannii, a frequent cause of difficult-to-treat infections in hospitals, researchers have identified a naturally occurring process that restores its vulnerability to antibiotics.
WashU Expert: The skinny on today’s new Oreo
Why downsize the O-R-E-O? Joseph Goodman, PhD, associate professor of marketing at Washington University in St. Louis’ Olin Business School, it’s a matter of matching tastes to the market.
Cooper named head of biochemistry and molecular biophysics
John A. Cooper, MD, PhD, has been named head of the Department of Biochemistry and Molecular Biophysics at Washington University School of Medicine.
WashU Expert: What ‘World of Warcraft’ teaches us about motivation
“World of Warcraft” might not seem like typical research material. But Yulia Nevskaya, PhD, assistant professor of marketing at Olin Business School at Washington University in St. Louis found it the perfect research platform. She has helped lead a study of gamers’ behavior and what’s behind their motivation.
Encouraging diversity in the neurosciences
In an effort to increase diversity in the neurosciences, Washington University in St. Louis has received a five-year, $1.5 million federal grant to participate in a national pipeline program with that mission.
New drugs to treat deadly heart condition aim of $3.1 million study
Jianmin Cui, PhD, professor of biomedical engineering in the School of Engineering & Applied Science, is taking an innovative approach to finding new drug candidates to treat Long QT syndrome with a four-year, $3.1 million grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health.
Siteman Cancer Center earns highest rating from federal cancer institute
The National Cancer Institute (NCI) has awarded Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis an “exceptional” rating, based on a rigorous review of Siteman’s research programs. The rating is the highest possible by the NCI, the principal federal institute that funds cancer research.
Stohler named managing director of asset allocation
Michael L. Stohler, PhD, has been named managing
director of asset allocation at the Washington University Investment
Management Company – the investment office for the endowment at
Washington University. In this capacity, Stohler
will play a key role in the overall management of the university’s
endowment and other assets.
Midlife changes in Alzheimer’s biomarkers may predict dementia
Studying brain scans and cerebrospinal fluid of healthy
adults, scientists have shown that changes in key markers of
Alzheimer’s disease during midlife may help identify those who will
develop dementia years later, according to new research.
Snapshots 7.6.15: St. Louis pride
Images captured in and around the Washington University campuses.
View More Stories